Clinical Trial Update: Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A two-cohort phase 1/2 clinical trial is investigating niraparib and dostarlimab with chemotherapy and radiotherapy in locally advanced head and neck squamous c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)
• Zejula (Niraparib)

Snippet

Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING